SCHEMBL11575529

SCHEMBL11575529

NC(=O)c1cccc2c1CCNCC2c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.52
DRD1 P21728 17/20 0.52
DRD2 P14416 10/20 0.52
KDM4E B2RXH2 5/20 0.52
MAPT P10636 3/20 0.52
DRD5 P21918 3/20 0.52
CYP3A4 P08684 2/20 0.52
NFKB1 P19838 2/20 0.52
THPO P40225 2/20 0.52
HIF1A Q16665 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
PKM P14618 1/20 0.52
RECQL P46063 1/20 0.52
MTOR P42345 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MAPK1 P28482 2/20 0.51
BLM P54132 2/20 0.51
GFER P55789 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11286208 0.89 TAAR1 (0.55) TAAR1DRD1DRD2KDM4EMAPT
SCHEMBL458574 0.80 GID4 (0.62) DRD1DRD2CYP3A4CYP2D6RECQL
SCHEMBL16835251 0.76 HTR2C (0.61) TAAR1DRD1DRD2KDM4EMAPT
SCHEMBL11294418 0.76 TAAR1 (0.55) TAAR1DRD1DRD2KDM4EMAPT
Bromide SCHEMBL16241877 0.75 HTR2C (0.60) TAAR1DRD1DRD2KDM4EMAPT
SCHEMBL11540905 0.71 DRD1 (0.53) TAAR1DRD1DRD2KDM4EMAPT
SCHEMBL2566292 0.70 TAAR1 (0.97) TAAR1DRD1DRD2KDM4EMAPT
Maleic Acid SCHEMBL8147693 0.70 TAAR1 (0.76) TAAR1DRD1DRD2KDM4EMAPT
Fumaric Acid SCHEMBL8147697 0.70 TAAR1 (0.76) TAAR1DRD1DRD2KDM4EMAPT
SCHEMBL11542130 0.69 DRD1 (0.70) TAAR1DRD1DRD2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4165372-A 6-Carboxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds and use as dopaminergic agents SMITHKLINE CORPORATION (US) 1979-08-21 US disclosed